Cited by 346Protease and Inhibitor MechanismsNF-κB Signaling PathwaysBlood Coagulation and Thrombosis Mechanisms

Tumor necrosis factor-α converting enzyme

Black, Roy A·2002·The International Journal of Biochemistry & Cell Biology

Abstract

Tumor necrosis factor-alpha converting enzyme (TACE/ADAM17/CD156q) is a member of the 'A Disintegrin And Metalloprotease', or ADAM, family. It is a multi-domain, type I transmembrane protein that includes an extracellular zinc-dependent protease domain. TACE expression is largely constitutive, but the surface pool is downregulated following cell activation. Cleavage by TACE generates the soluble forms of tumor necrosis factor, transforming growth factor-alpha, and other proteins from their membrane-bound precursors (a phenomenon termed 'shedding'). The recognition of substrates by TACE is poorly understood, but sites distal to the active site are probably involved, and in at least some cases both enzyme and substrate must be membrane-anchored. Cell-activators increase the rate of shedding. Activator-induced shedding is mediated by intracellular kinase cascades, but how these cascades affect the shedding machinery is unknown. The pharmaceutical industry is attempting to design specific TACE inhibitors to treat inflammatory diseases.

Integrity signals

Registry

Crossref · 10.1016/s1357-2725(01)00097-8

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Black, R. A.
Corresponding author
Black, Roy A
Venue
The International Journal of Biochemistry & Cell Biology
Publisher
Elsevier BV
Published
2002-01
Volume
34
Issue
1
Pages
1-5
ISSN
1357-2725 (ISSN-L)
OpenAlex
W2014886449
Cited by
346
References
35
Citations by year
2026: 2 · 2025: 4 · 2024: 4 · 2023: 7 · 2022: 8 · 2021: 10 · 2020: 3 · 2019: 7 · 2018: 10 · 2017: 7 · 2016: 7 · 2015: 13 · 2014: 13 · 2013: 19 · 2012: 15
FWCI
13.76
Type
journal article
Language
en
Open access
closed
Locations
  • The International Journal of Biochemistry & Cell Biology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords
ADAM17, ADAM family, zinc-dependent protease, soluble TNF, transforming growth factor-alpha, substrate recognition, cell activation, kinase cascade, TACE inhibitors, inflammatory diseases
MeSH terms
ADAM17 Protein, Animals, Humans, Metalloendopeptidases, Mutation, Tumor Necrosis Factor-alpha, Molecular Structure, Mice, ADAM Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review